Background Stem cell therapy is becoming an emerging therapeutic option for chronic liver
disease (CLD). However, whether stem cell therapy is more effective than conventional …

Acute and chronic liver diseases are the major cause of high morbidity and mortality
globally. Liver transplantation is a widely used therapeutic option for liver failure. However …

Background Cholestatic liver fibrosis (CLF) is caused by inflammatory destruction of the
intrahepatic bile duct and abnormal proliferation of the small bile duct after cholestasis …

The liver is the organ with the highest regenerative capacity in the human body. However,
various insults, including viral infections, alcohol or drug abuse, and metabolic overload …

Hepatocellular carcinoma (HCC) is a major health problem worldwide, especially for
patients who are suffering from end-stage liver disease (ESLD). The ESLD is considered a …

Introduction According to the recent updates from World Health Organization, liver diseases
are the 12th most common cause of mortality. Currently, orthotopic liver transplantation …

Background aims Cirrhosis is the 11th leading cause of death worldwide. Because of the
limitations of liver transplantation, cell-and granulocyte colony-stimulating factor (G-CSF) …

Stem cell therapy remains in its infancy though may have a major role in the future of
regenerative medicine and in particular for the treatment of NAFLD and NASH, either alone …

目的探讨骨髓巨噬细胞M2 亚型(M2-BMDM) 共培养后的骨髓间充质干细胞(BMSC M2)
移植对四氯化碳/2-乙酰氨基芴(CCl4/2-AAF) 诱导肝硬化大鼠模型进展的影响 …

Currently, liver transplantation is the best way to improve the survival rate of decompensated
cirrhosis, but its application is limited due to the shortage of donors and high cost. In the …